Literature DB >> 34370877

Experimental models of Barth syndrome.

William T Pu1,2.   

Abstract

Mutation of the gene Tafazzin (TAZ) causes Barth syndrome, an X-linked disorder characterized by cardiomyopathy, skeletal muscle weakness, and neutropenia. TAZ is an acyltransferase that catalyzes the remodeling of cardiolipin, the signature phospholipid of the inner mitochondrial membrane. Here, we review the major model systems that have been established to study the role of cardiolipin remodeling in mitochondrial function and the pathogenesis of Barth syndrome. We summarize key features of each model and provide examples of how each has contributed to advance our understanding of TAZ function and Barth syndrome pathophysiology.
© 2021 SSIEM.

Entities:  

Keywords:  Barth syndrome; cardiolipin; disease model; tafazzin

Mesh:

Substances:

Year:  2021        PMID: 34370877      PMCID: PMC8814986          DOI: 10.1002/jimd.12423

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  65 in total

1.  A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function.

Authors:  Zaza Khuchua; Zou Yue; Lorene Batts; Arnold W Strauss
Journal:  Circ Res       Date:  2006-06-22       Impact factor: 17.367

2.  Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome.

Authors:  Jan Dudek; I-Fen Cheng; Martina Balleininger; Frédéric M Vaz; Katrin Streckfuss-Bömeke; Daniela Hübscher; Milena Vukotic; Ronald J A Wanders; Peter Rehling; Kaomei Guan
Journal:  Stem Cell Res       Date:  2013-05-28       Impact factor: 2.020

3.  Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.

Authors:  Cunqi Ye; Wenjia Lou; Yiran Li; Iliana A Chatzispyrou; Maik Hüttemann; Icksoo Lee; Riekelt H Houtkooper; Frédéric M Vaz; Shuliang Chen; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2013-12-08       Impact factor: 5.157

4.  A Drosophila model of Barth syndrome.

Authors:  Yang Xu; Morgan Condell; Heide Plesken; Irit Edelman-Novemsky; Jinping Ma; Mindong Ren; Michael Schlame
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-19       Impact factor: 11.205

5.  Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.

Authors:  Devrim Acehan; Frederic Vaz; Riekelt H Houtkooper; Jeanne James; Vicky Moore; Chonan Tokunaga; Willem Kulik; Janaka Wansapura; Matthew J Toth; Arnold Strauss; Zaza Khuchua
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

6.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.

Authors:  Xiaojun Lian; Jianhua Zhang; Samira M Azarin; Kexian Zhu; Laurie B Hazeltine; Xiaoping Bao; Cheston Hsiao; Timothy J Kamp; Sean P Palecek
Journal:  Nat Protoc       Date:  2012-12-20       Impact factor: 13.491

7.  Characterization of tafazzin splice variants from humans and fruit flies.

Authors:  Yang Xu; Shali Zhang; Ashim Malhotra; Irit Edelman-Novemsky; Jinping Ma; Antonina Kruppa; Carolina Cernicica; Steven Blais; Thomas A Neubert; Mindong Ren; Michael Schlame
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

8.  Seven functional classes of Barth syndrome mutation.

Authors:  Kevin Whited; Matthew G Baile; Pamela Currier; Steven M Claypool
Journal:  Hum Mol Genet       Date:  2012-10-24       Impact factor: 6.150

Review 9.  A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?

Authors:  Mindong Ren; Paighton C Miller; Michael Schlame; Colin K L Phoon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-11       Impact factor: 4.733

10.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.

Authors:  Gang Wang; Megan L McCain; Luhan Yang; Aibin He; Francesco Silvio Pasqualini; Ashutosh Agarwal; Hongyan Yuan; Dawei Jiang; Donghui Zhang; Lior Zangi; Judith Geva; Amy E Roberts; Qing Ma; Jian Ding; Jinghai Chen; Da-Zhi Wang; Kai Li; Jiwu Wang; Ronald J A Wanders; Wim Kulik; Frédéric M Vaz; Michael A Laflamme; Charles E Murry; Kenneth R Chien; Richard I Kelley; George M Church; Kevin Kit Parker; William T Pu
Journal:  Nat Med       Date:  2014-05-11       Impact factor: 53.440

View more
  2 in total

Review 1.  Barth Syndrome Cardiomyopathy: An Update.

Authors:  Jing Pang; Yutong Bao; Kalia Mitchell-Silbaugh; Jennifer Veevers; Xi Fang
Journal:  Genes (Basel)       Date:  2022-04-08       Impact factor: 4.141

2.  Re-Expression of Tafazzin Isoforms in TAZ-Deficient C6 Glioma Cells Restores Cardiolipin Composition but Not Proliferation Rate and Alterations in Gene Expression.

Authors:  Gayatri Jagirdar; Matthias Elsner; Christian Scharf; Stefan Simm; Katrin Borucki; Daniela Peter; Michael Lalk; Karen Methling; Michael Linnebacher; Mathias Krohn; Carmen Wolke; Uwe Lendeckel
Journal:  Front Genet       Date:  2022-07-25       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.